Page 2 - Abbott India
Nestle, Abbott India, Asian Paints, Pidilite hit new highs on good earnings
Nestle India gained 4% to Rs 12,266 apiece, surging 7% during current week, after the company reported a 11% year-on-year (YoY) rise in net profit to Rs 438 crore for the quarter ended June 2019.
 "Nestle, Abbott India, Asian Paints, Pidilite hit new highs on good earnings")
Abbott India Q3 net up marginally at Rs 117 cr, revenue rises to Rs 947 cr
Abbott India's revenue from operations of the company stood at Rs 947.65 crore for the third quarter
 "Abbott India Q3 net up marginally at Rs 117 cr, revenue rises to Rs 947 cr")
Abbott India ups vaccines play, to launch products in infant segment
According to analysts, AIL's presence in the high-margin vaccine segment is likely to drive its future growth
Abbott looks beyond product portfolio to generate trust and recall
The pharma major walks around the prescribed lines to build a corporate identity beyond the medicines in its Indian portfolio
 "Abbott looks beyond product portfolio to generate trust and recall")
Abbott excels on power of brands, outpaces MNC peers on sales growth
The growth has come at a time when GST implementation affected most Indian pharma companies including Abbott's MNC peers
 "Abbott excels on power of brands, outpaces MNC peers on sales growth")
Abbott India Q2 net surges 83% at Rs 138 cr on robust sales
The total income of the company also rose to Rs 946.04 crore for the July-September quarter of 2017-18
Abbott India soars 20% on strong Q2 results
The stock was locked in upper circuit of 20% at Rs 5,401, also its 52-week high on the BSE.
 "Abbott India soars 20% on strong Q2 results")
NPPA allows Abbott to discontinue bioresorbable stent over safety concerns
NPPA decided to allow withdrawal under exceptional circumstances and by relaxing mandatory six months prior intimation in public interest
 "NPPA allows Abbott to discontinue bioresorbable stent over safety concerns")
Abbott to discontinue sales of fully biodegradable stent
Abbott has been trying to withdraw its stent from India since the NPPA capped coronary stent prices
Abbott India Q1 net profit down 35% at Rs 48 crore
The firm had posted the net profit of Rs 74.01 crore in the same quarter last financial year
 "Abbott India Q1 net profit down 35% at Rs 48 crore")
Chemists lock horns with Abbott over expired drugs
Regular disposal of medicines is for preventing contamination, toxicity and drug resistance
 "Chemists lock horns with Abbott over expired drugs")
Did Abbot use India's doctor-pharma nexus to push through an untested drug?
Health camps have become an industry-wide marketing gimmick in India
Abbott India names Ambati Venu as MD
In February this year, Abbott India announced resignation of its managing director Rehan A Khan
